Skip to content
Menu

TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and lowers the price target from $40 to $37.

TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and lowers the price target from $40 to $37.

Read at benzinga.com